Molecular-genetic imaging: A nuclear medicine-based perspective

Molecular Imaging

Volumn 1, Issue 3, 2002, Pages 280-300

  Blasberg, Ronald G ^a   Gelovani, Juri ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FIAU; Gamma camera; Gen imaging; Herpes virus type one thymidine kinase; HSV1 tk; Molecular imaging; NFAT; p53; PET; T cell activation

Indexed keywords

DISEASE CONTROL; GENETIC ENGINEERING; MAGNETIC RESONANCE IMAGING; NONINVASIVE MEDICAL PROCEDURES; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; TISSUE;

GENE IMAGING;

MEDICAL IMAGING;

ADOPTIVE TRANSFER; ANIMAL; AUTORADIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENETIC MARKER; HUMAN; IMAGE PROCESSING; METHODOLOGY; MOLECULAR BIOLOGY; NUCLEAR MEDICINE; REPORTER GENE; REVIEW;

ADOPTIVE TRANSFER; ANIMALS; AUTORADIOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC MARKERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MOLECULAR BIOLOGY; NUCLEAR MEDICINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0012473447     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002760235472     Document Type: Review

References (80)

1. Wick RA (1989). Photon counting imaging: Applications in biomedical research. Biotechniques. 3:262-269.
2. Hooper CE, Ansorge RE, Browne HM, Tomkins P (1990). CCD imaging of luciferase gene expression in single mammalian cells. J Biol Chem. 2:123-130.
3. Dooley TP, Stamp-Cole M, Ouding RJ (1993). Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells. Lab Anim Sci. 43:48-57.
4. Welsh S, Kay SA (1997). Reporter gene expression for monitoring gene transfer. Curr Opin Biotechnol. 5:617-622.
5. Weissleder R, Reimer P, Lee AS, Wittenberg J, Brady TJ (1990). MR receptor imaging: Ultra small iron oxide particles targeted to asialoglycoprotein receptors. Am J Roentgenol. 6:1161-1167.
6. Weissleder R, Lee AS, Fischman AJ, Reimer P, Shen T, Wilkinson R, Callahan RJ, Brady TJ (1991). Polyclonal human immunoglo-bulin G labeled with polymeric iron oxide: Antibody MR imaging. Radiology. 1:245-249.
7. Kayyem JF, Kumar RM, Fraser SE, Meade TJ (1995). Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol. 9:615-620.
8. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, Bogdanov A (1997). MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 2:425-429.
9. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 3:321-325.
10. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe H, Gansbacher B, Blasberg RG (1995). Imaging the expression of transfected genes in vivo. Cancer Res. 55:6126-6132.
11. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, Blasberg RG (1996). Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res. 56:4087-4095.
12. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, Blasberg R (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography, Cancer Res. 58:4333-4341.
13. Gambhir SS, Barrio JR, Wu L, Iyer M, Namavari M, Satyamurthy N, Bauer E, Parrish C, MacLaren DC, Borghei AR, Green LA, Sharfstein S, Berk AJ, Cherry SR, Phelps ME, Herschman HR (1998). Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med. 11:2003-2011.
14. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry, SR, Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci, USA. 5:2333-2338.
15. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA. (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol. 66:523-531.
16. Contag PR, Olomu IN, Stevenson DK, Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med. 4:245-247.
17. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 6:491-495.
18. Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R, Tjuvajev G (2001). Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci, USA. 98:9300-9305.
19. Harrington KJ, Linardakis E, Vile RG (2000). Transcriptional control: An essential component of cancer gene therapy strategies. Adv Drug Deliv Rev. 2-3:167-184.
20. Fussenegger M (2001). The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies, Biotechnol Prog. 1:1-51.
21. Nakagawa S, Massie B, Hawley RG (2001). Tetracycline-regulatable adenovirus vectors: Pharmacologic properties and clinical potential. Eur J Pharm Sci. 1:53-60.
22. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM (1993). Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 53:977-984.
23. Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M (1997). Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med. 38:1348-1351.
24. Tan B, Piwnica-Worms D, Ratner L (2000). Multidrug resistance transporters and modulation. Curr Opin Oncol. 12:450-458.
25. Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caraco C, Fonti R, Botti G, D'Aiuto G, Salvatore M (2002). Dynamic coupling of (99m)Tc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients. Eur J Nucl Med Mol Imaging. 29:809-814.
26. Behr TM, Gotthardt M, Earth A, Behe M (2001). Imaging tumors with peptide-based radioligands. Q J Nucl Med. 2:189-200.
27. Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, Dewanjee S, Serafini AN, Lopes DM, Sfakianakis GN (1994). Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med. 6:1054-1063.
28. Cammilleri S, Sangrajrang S, Perdereau B, Brixy F, Calvo F, Bazin H, Magdelenat H (1996). Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection. Eur J Nucl Med. 4:448-452.
29. Phillips JA, Craig SJ, Bayley D, Christian RA, Geary R, Nicklin PL (1997). Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochem Pharmacol. 6:657-668.
30. Tavitian B, Terrazzino S, Kuhnast B, Marazabal S, Stettler O, Dolle F, Deverre JR, Jobert A, Hinnen F, Bendriem B, Crouzel C, Di Giamberadio L (1998). In vivo imaging of oligonucleotides with positron emission tomography. Nat Med. 4:467-471.
31. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Gallagher B, Huffman E, Alavi A, Sokoloff L (1977). Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-D-glucose. Acta Neurol Scand. 64:S190-S191.
32. Sokoloff L, Reivich M, Kennedy C, Des Roslers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977). The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 5:897-916.
33. Sokoloff L (1976). [1-14C]-2-deoxy-D-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants. Neurosci Res Prog Bull. 4:466-468.
34. Sokoloff L (1984). Metabolic probes for localization of functional activity in the central nervous system. Int J Neurol. 18:40-48.
35. Schmidt KC, Lucignani G, Sokoloff L (1996). Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: A re-examination. J Nucl Med. 2:394-399.
36. Jones DE Jr, Cui DM, Miller DM (1995). Expression of betagalactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin. Oncogene. 12:2323-2330.
37. Zhang L, Adams JY, Billick E, Ilagan R, Iyer M, Le K, Smallwood A, Gambhir SS, Carey M, Wu L (2002). Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther. 3:223-232.
38. Green LA, Nguyen K, Bauer E, Barrio JR, Namavari M, Satyamurthy N, Tokokuni T, Phelps ME, Sandgren EP, Herchmann HR, Gambhir SS (2000); Indirect monitoring of endogenous gene expression by imaging PET reporter gene expression in transgenic mice. J Nucl Med. p. 81S.
39. Qiao J, Doubrovin M, Sauter MV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg R, Tjuvajev JG, Chen SH, Woo SLC (2002). Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 9:168-175.
40. Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornmann W, Finn R, Akhurst T, Larson S, Blasberg R, Sadelian M, Tjuvajev JG (2001). Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 3:480-488.
41. Ray P, Pimenta H, Paulmurugan R, Berger F, Phelps ME, Iyer M, Gambhir SS (2002). Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci, USA. 5:3105-3110.
42. Mayer-Kuckuk P, Banerjee D, Malhotra S, Doubrovin M, Iwamoto M, Akhurst T, Balatoni J, Bornmann W, Finn R, Larson S, Fong Y, Tjuvajev JG, Blasberg R, Bertino JR (2002). Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression. Proc Natl Acad Sci, USA. 6:3400-3405.
43. Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, Iyer M, Namavari M, Phels ME, Herchman HR (2000). A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci, USA. 6:2785-2790.
44. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herchman HR (1999). Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 5:785-791.
45. Rogers BE, McLean SF, Kirkman RL, Della Manna D, Bright SJ, Olsen CC, Myracle AD, Mayo MS, Curiel DT, Buchsbaum DJ (1999). In vivo localization of [(111)In]-DTPA-D-Phel-octreotlde to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res. 2:383-393.
46. Rogers BE, Zinn KR, Buchsbaum DJ (2000). Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med. 3:208-223.
47. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM (1996). Cloning of the human sodium Iodide symporter. Btochem Biophys Res Commun. 2:339-345.
48. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE (1998). Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab. 5:1746-1751.
49. Haberkorn U (2001). Gene therapy with sodium/iodide symporter in hepatocarcinoma, Exp Clin Endocrinol Diabetes. 1:60-62.
50. 18F]fluoroethyl)spiperone: In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans, J Cereb Blood Flow Metab. 9:830-839.
51. Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buschsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT, Alvarez RD (2001). An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol Ther. 3:223-231.
52. Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn IM (2001). Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues, Nucl Med Biol. 7:829-834.
53. Jolly D (1994). Viral vector systems for gene delivery. Cancer Gene Ther. 1:51-64.
54. 124I]FIAU and PET. Mol Imaging. 1:36-42.
55. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg R (1999). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59:5186-5193.
56. Bennett JJ, Tjuvajev JG, Johnson P, Doubrovin M, Akhurst T, Malholtra S, Hackman T, Balatoni J, Finn R, Larson SM, Federoff H, Blasberg R, Fong Y (2001). Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med. 7:859-863.
57. Jacobs A, Tjuvajev JG, Doubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herlinger U, Pechan PA, Chiocca EA, Breakefelid XO, Blasberg RG (2001). Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61:2983-2995.
58. Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Balatoni J, Finn R, Larson SM, Sadelain M, Blasberg RG (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia. 4:315-320.
59. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, Cherry SR, Phelps ME, Herschman HR, Gambhir SS (2000). Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med. 8:933-937.
60. Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS (2001). Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 14:1072-1080.
61. Pelletier S (1988). Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:320-325.
62. Sachs AB, Sarnow P, Hentze MW (1997). Starting at the beginning, middle, and end: Translation initiation in eukaryotes. Cell. 89:831-838.
63. Merritt JA, Roth JA, Logothetis CJ (2001). Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studies, Semin Oncol. 16:S105-14.
64. Serganova I, Beresten T, Ageyeva L, Ponomarev V, Doubrovin M, Songhomoyan S, Vider L, Balatoni J, Finn R, Blasberg R, Gelovani Tjuvajev J (2002). Imaging in hypoxia-induced HIF-1α signaling by PET. The 49th Society of Nuclear Medicine Conference, Los Angeles, CA, June 15-19, 2002. J Nucl Medicine. 43:69P.
65. Serganova I, Ponomarev V, Doubrovin M, Ageyeva L, Beresten T, Songhomoyan S, Balatoni J, Finn R, Blasberg R, Massague J, Gelovani Tjuvajev J (2002). Imaging TGFβ signal transduction pathway activity with PET, The 49th Society of Nuclear Medicine Conference, Los Angeles, CA, June 15-19, 2002. J Nucl Medicine. 43:69P.
66. Doubrovin M, Chen SH, Ponomarev V, Balatoni J, Finn R, Blasberg R, Woo S, Tjuvajev J (2000). Noninvasive imaging of CEA-specific expression of adenoviral-mediated HSV1-tk gene transfer in tumors using a trans-reporter system. 3rd Annual Meeting of the American Society of Gene Therapy, Denver, CO.
67. Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS (2001). Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci, USA. 25:14595-14600.
68. Luker GD, Sharma V, Pica CM, Dahlheimer JL, Li W, Ochesky J, Ryan CE, Piwnica-Worms H, Piwnica-Worms D (2002). Non-invasive imaging of protein-protein interactions in living animals, Proc Natl Acad Sci, USA. 99:6961-6966.
69. Ponomarev V, Dubrovin M, Beresten T, Balatoni J, Blasberg RG, Tjuvajev J (2000). Optimization of a reporter gene for dual-modality imaging of transgene expression.J Nucl Med. 41:81p.
70. Ponomarev V, Doubrovin M, Beresten T, Balatoni J, Blasberg RG, Tjuvajev JG (2000). Optimization of a reporter gene for dual-modality imaging of transgene expression. Abstr. 47th Annual Meeting of the Society of Nuclear Medicine, St. Louis, MO, June 3-7, 2000. J Nucl Medicine. 41:81P.
71. Ercikan-Abali EA, Banerjee D, Waltham MC, Skacel N, Scotto KW, Bertino JR (1997). Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region, Biochemistry. 7:12317-12322.
72. Ercikan-Abali EA, Banerjee D, Waltham MC, Schnieders B, Scotto KW, Bertino JR (1993). Translational regulation of the synthesis of dihydrofolate reductase. Adv Exp Med Biol 338:537-540.
73. Chu E, Voeller D, Jones KL, Drake JC, Takimoto CH, Maley GF, Maley F, Allegra CJ (1993). Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cell. Biochemistry. 32:4756-4760.
74. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SJ (1990). Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 323:570-578.
75. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995). Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13.
76. Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Traversari C, Bordignon C (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther. 9:2243-2251.
77. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C (1997). HSV-TK gene transfer into donor lymphocytes for control of allogenic graft-versus-leukemia, Science. 276:1719-1724.
78. Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B (2000). Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 11:1465-1475.
79. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, McCarthy T, McCarthy DW, Gambhir SS (2002). Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci, USA. 99:3030-3035.
80. Doubrovin M, Doubrovina E, Balatoni J, Ivanova A, Ponomarev V, O'Reilly R, Finn R, Blasberg R, Gelovani J (2002). Long-term monitoring if antigen-specific in vivo labeled Cytotoxic T Lymphocytes (CTL); AACR Conference "Molecular Imaging in Cancer", (Abstract). Molecular Imaging. 1:117P.